RAYMOND COLES: Open Payments
NPI 1255694782 · HADDONFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$365 in 21 payments from 9 companies in 2025. Trend: 2023 $503 · 2024 $1,110 · 2025 $365
Food & beverage: $365
| Company | Payments | Amount |
|---|---|---|
| SCILEX PHARMACEUTICALS INC. | 7 | $121 |
| Collegium Pharmaceutical, Inc. | 5 | $83 |
| IBSA Pharma Inc. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Foundation Fusion Solutions, LLC | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| SI-BONE, INC. | 1 | $17 |
| Valinor Pharma, LLC | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: ZTLido, Belbuca, XTAMPZA, Tirosint, RELISTOR, OCTRODE, MOVANTIK, JOURNAVX.
Industry payments across NJ — which companies pay providers there.
